Top Markets
#1 ADO Protocol ADO Protocol +324.24%
#2 Islamic Coin Islamic Coin +155.36%
#3 GoPlus Security GoPlus Security +51.83%
#4 Starpower Starpower +34.32%
#5 Verus Coin Verus Coin +33.01%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +14.40%
#8 o1.exchange o1.exchange +12.87%
#9 Lumia Lumia +10.89%
#10 Status Status +10.42%
Coin of the day
ADO Protocol ADO Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Ocean Biomedical, Inc. Ocean Biomedical, Inc.

Ocean Biomedical, Inc.

OCEAW
Rang in Aktien #33294
Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in... Ocean Biomedical, Inc. is a biopharmaceutical enterprise primarily engaged in identifying and advancing novel therapeutic agents. Their research and development efforts span several key disease areas, including cancer, fibrotic conditions, infectious illnesses, and inflammatory disorders. The company's current development pipeline features both mono-specific and bi-specific humanized monoclonal antibodies (mAbs). These candidates are engineered to target Chi3l1 and are being investigated for treating non-small cell lung cancer and glioblastoma multiforme, a type of brain tumor. Furthermore, Ocean Biomedical is progressing a small molecule therapeutic designed to interact with Chit1, intended for individuals afflicted with Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome. Their proprietary WPDS platform has generated three additional product candidates: a vaccine aimed at preventing malaria; a humanized monoclonal antibody treatment; and a small molecule treatment, with both malaria therapeutics specifically targeting the Plasmodium falciparum glutamic-acid-rich protein (PfGARP). The company is also developing a therapy for hospitalized patients suffering from COVID-19. Founded in 2019, Ocean Biomedical's operations are headquartered in Providence, Rhode Island.
Aktienkurs
$0.0298
Zuletzt synchronisiert: 2026-02-10
Marktkapitalisierung
$7.94M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
664.10%
Land
US
Handel Ocean Biomedical, Inc. (OCEAW)

Kategorie

Healthcare
Kursverlauf für Ocean Biomedical, Inc. (OCEAW)
Höchster Schlusskurs: $0.03 am 2026-02-01

Niedrigster Schlusskurs: $0.25 am 2023-02-01
Kursverlauf der Aktie von Ocean Biomedical, Inc. von 2023 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -68.78%
2025 -12.05%
2024 13.45%
2023 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $737.68 7.34%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $254.55 12.96%
BE